| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 05/17/2001 | WO2001034636A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | WO2001033957A1 Transgenic non-human mammals for monitoring change in calcium ion concentration in cells |
| 05/17/2001 | WO2001033956A1 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | WO2001033955A1 Animal models for cardiac disease |
| 05/17/2001 | WO2001033954A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | WO2001020003A3 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof |
| 05/17/2001 | WO2001019183A3 Development of an effective gene transfer technique for introducing foreign dna into sperm cells |
| 05/17/2001 | WO2001002593A3 Control of gene expression in eukaryotic cells |
| 05/17/2001 | WO2000030437A9 Transgenic animals |
| 05/17/2001 | CA2390995A1 Recombinant gelatin in vaccines |
| 05/17/2001 | CA2390740A1 Melanocortin-4 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | CA2390723A1 Melanocortin-3 receptor deficient cells, non-human transgenic animals and methods of selecting compounds which regulate body weight |
| 05/17/2001 | CA2390504A1 Cytochrome p450 oxygenases and their uses |
| 05/17/2001 | CA2390161A1 Methods for identifying and using amyloid-inhibitory compounds |
| 05/17/2001 | CA2389550A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | CA2388477A1 Recombinant gelatins with uniform molecular weight |
| 05/17/2001 | CA2325226A1 Use of polypeptides or nucleic acids encoding these for the diagnosis or treatment of skin disorders, and their use for the identification of pharmacologically active substances |
| 05/16/2001 | EP1098986A2 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
| 05/16/2001 | CN1295543A Treatment of waste materials |
| 05/15/2001 | US6232524 Live mouse mutagenesis systems for testing mutagenic agents in vivo |
| 05/15/2001 | US6232523 To study tumor progresssion in vertebrates; stably transformed tumor cell line transfected with expression vector nucleotide sequence under control of viral promoter; continued expression through cell line proliferation |
| 05/15/2001 | US6232447 Antibody immunoreactive with a human cytokine designated LERK-6 |
| 05/15/2001 | US6232094 DNA encoding human κ casein and process for obtaining the protein |
| 05/10/2001 | WO2001033199A2 Universal fluorescent sensors |
| 05/10/2001 | WO2001032685A2 Gene expression directed by a super-psa promoter |
| 05/10/2001 | WO2001032186A2 Inhibitors of the inositol polyphosphate 5-phosphatase ship2 molecule |
| 05/10/2001 | WO2001032126A2 Congenic animal models of non-insulin dependent diabetes mellitus |
| 05/10/2001 | WO2001032009A1 Propagation of human hepatocytes in non-human animals |
| 05/10/2001 | WO2001032008A1 Methods for sexing non-human mammals |
| 05/10/2001 | WO2000077207A3 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 05/10/2001 | WO2000077035A3 Novel potassium channels and genes encoding these potassium channels |
| 05/10/2001 | WO2000072666A3 USE OF TRANSGENIC MICE LACKING JunB EXPRESSION IN THE MYELOID LINEAGE |
| 05/10/2001 | WO2000034334A9 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
| 05/10/2001 | CA2389906A1 Methods for sexing non-human mammals |
| 05/10/2001 | CA2389852A1 Congenic animal models of non-insulin dependent diabetes mellitus |
| 05/10/2001 | CA2389646A1 Propagation of human hepatocytes in non-human animals |
| 05/10/2001 | CA2389335A1 Gene expression directed by a super-psa promoter |
| 05/09/2001 | EP1097719A1 NEP inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097718A1 NPY antagonists for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097713A1 Inhibitors of the inositol polyphosphate 5-phosphatase ship-2 molecule |
| 05/09/2001 | EP1097707A1 Treatment of female sexual dysfunction |
| 05/09/2001 | EP1097706A1 Phosphodiesterase inhibitors for the treatment of female sexual dysfunction |
| 05/09/2001 | EP1097215A1 Conditional mutants of influenza virus m2 protein |
| 05/09/2001 | EP1097210A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 05/09/2001 | EP1097167A2 Neurotrophic growth factor |
| 05/09/2001 | EP1096955A2 Cancer treatment methods using antibodies to aminophospholipids |
| 05/09/2001 | EP1096946A2 Delta cleavage products and methods based thereon |
| 05/09/2001 | EP1096850A1 A process of cell reprogramming through production of a heterokaryon |
| 05/09/2001 | CN2428952Y Multifunctional adjustable apparatus for establishing magnetic pulses, electric fields and acoustic fields |
| 05/09/2001 | CN1294631A Control of gene expression |
| 05/09/2001 | CN1293891A Method, special bait and special apparatus for raising crocodile |
| 05/08/2001 | US6228835 Decorin binding protein compositions |
| 05/08/2001 | US6228639 Vectors and methods for the mutagenesis of mammalian genes |
| 05/08/2001 | US6228356 Viral vectors to inhibit leukocyte infiltration or cartilage degradation of joints |
| 05/08/2001 | CA2324484A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323464A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323191A1 Compounds for the treatment of female sexual dysfunction |
| 05/08/2001 | CA2323183A1 Compounds for the treatment of female sexual dysfunction |
| 05/03/2001 | WO2001031029A2 Human sphingosine kinase gene |
| 05/03/2001 | WO2001031021A1 Multiple sclerosis-related superantigen |
| 05/03/2001 | WO2001030980A2 Methods and compositions for enhancing developmental potential of oocytes and zygotes |
| 05/03/2001 | WO2001030845A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
| 05/03/2001 | WO2001030798A1 Transgenic mice containing trp gene disruptions |
| 05/03/2001 | WO2001030136A1 Breeding lines of color-sexable day-old chicks and methods for producing the same |
| 05/03/2001 | WO2000077168A3 ANTAGONISTS OF BMP AND TGFβ SIGNALLING PATHWAYS |
| 05/03/2001 | CA2389127A1 Human sphingosine kinase gene |
| 05/03/2001 | CA2389117A1 Methods and compositions for enhancing developmental potential of oocytes and zygotes |
| 05/03/2001 | CA2387680A1 Pablo, a polypeptide that interacts with bcl-xl, and uses related thereto |
| 05/02/2001 | EP1095279A1 Method for identifying a presenilinase inhibitor |
| 05/02/2001 | EP1095165A1 Method for identifying mutants and molecules |
| 05/02/2001 | EP1095156A2 Transgenic mouse expressing green fluorescent protein in astrocytes |
| 05/02/2001 | EP1095154A2 Interaction of human beta amyloid precursor protein (beta-app) with human lon-protease like protein (hslon) |
| 05/02/2001 | EP1095148A2 Cloning and characterisation of novel mammalian peptidases |
| 05/02/2001 | EP1095136A1 Cells and animals deficient in protein kinase c epsilon |
| 05/02/2001 | EP1095020A1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them |
| 05/02/2001 | EP0871366A4 Food product and process |
| 05/02/2001 | CN1292994A Method for breading protospecies of black-feather layer of green-shell egg |
| 05/01/2001 | US6225525 ATP-binding cassette transporter (ABC1) modified transgenic mice |
| 05/01/2001 | US6225486 Composition comprising mixture of free fatty acid conjugated linoleic acid isomers containing at least approximately 92 per cent trans 10, cis 12-octadecadienoic acid |
| 05/01/2001 | US6225084 Nucleotide and amion acid sequence of genes that are up-regulated in endothelial cells subjected to shear stress; atherosclerosis, antiischemic agents; hypotensive agents; restenosis; antiinflammatory agents for arteries |
| 05/01/2001 | US6224879 Genetic engineering |
| 05/01/2001 | US6223687 High efficiency vermiculture process and apparatus |
| 05/01/2001 | CA2081660C Method for improving the organoleptic qualities of the meat from uncastrated male domestic animals and vaccine set for use in this method |
| 04/26/2001 | WO2001029256A2 Cephalic pain susceptibility marker |
| 04/26/2001 | WO2001029255A2 Diagnostic test for cephalic pain |
| 04/26/2001 | WO2001029227A1 The beta-barrel of the lipid body lipoxygenase |
| 04/26/2001 | WO2001029208A1 Conditional gene trapping construct for the disruption of genes |
| 04/26/2001 | WO2001029205A2 Method for genetic manipulation |
| 04/26/2001 | WO2001029204A2 Protein production system |
| 04/26/2001 | WO2001029199A1 Methods for using 22045, a human cyclic nucleotide phosphodiesterase |
| 04/26/2001 | WO2001029129A1 Highly-neutralized ethylene copolymers and their use in golf balls |
| 04/26/2001 | WO2001029083A1 POLYNUCLEOTIDES ENCODING HUMAN AND MURINE ADHESION PROTEINS (BIgR) |
| 04/26/2001 | WO2001029082A1 A DNA MOLECULE ENCODING A VARIANT α2B-ADRENOCEPTOR PROTEIN, AND USES THEREOF |
| 04/26/2001 | WO2001028415A1 Animal health diagnosis |
| 04/26/2001 | WO2001028321A1 Diabetes onset model mammal |
| 04/26/2001 | WO2000071723A3 Methods for regulating protein conformation using molecular chaperones |
| 04/26/2001 | WO2000054581A3 Animal models and methods for sepsis |
| 04/26/2001 | DE19950921A1 New isolated nucleic acid encoding sequence that targets proteins to lipid bodies, useful for producing transgenic plants for lipid and fatty acid production |
| 04/26/2001 | CA2388305A1 The beta-barrel of the lipid body lipoxygenase |
| 04/26/2001 | CA2388032A1 Polynucleotides encoding human and murine adhesion proteins (bigr) |